基于综合老年评估的个体化干预逆转老年非透析CKD衰弱:随机对照试验
该随机对照试验纳入242例≥65岁、Fried衰弱评分≥3的非透析CKD 3-5期患者,1:1分配至12个月基于综合老年评估的个体化多域干预组或常规照护组。12个月时干预组衰弱逆转率显著高于对照组(30.6% vs 7.4%,P<0.001),年龄校正OR为5.22(95%CI 2.37-11.49);两组非计划住院和全因死亡无显著差异。
要点
- 基于CGA的个体化干预可安全有效地逆转老年非透析CKD患者衰弱。
- 12个月衰弱逆转率干预组30.6%,对照组7.4%,差异显著(P<0.001)。
- 干预未显著改善非计划住院或全因死亡,结论可能不适用于更晚期CKD。
核心结论
- 基于综合老年评估的个体化干预能有效且安全地逆转老年非透析CKD患者的衰弱。
- 干预对非计划住院和全因死亡无显著影响,结论可能不适用于更晚期CKD患者。
研究设计与样本
- 北京朝阳医院开展的随机对照试验,242例年龄≥65岁、Fried评分≥3的3-5期非透析CKD衰弱患者按1:1分组。
- 干预组接受12个月基于CGA的个体化多域方案(营养、心理、躯体功能),对照组接受常规照护。
主要发现
- 12个月时干预组衰弱逆转率为30.6%,对照组为7.4%,差异显著(P<0.001)。
- 年龄校正后,基于CGA的个体化干预与衰弱逆转可能性更高独立相关(OR 5.22,95%CI 2.37-11.49)。
- 两组非计划住院和全因死亡无显著差异。
关键数值与推荐
- 衰弱逆转定义:Fried衰弱评分从≥3转为<3。
- 纳入标准:年龄≥65岁、3-5期非透析CKD、Fried评分≥3;排除预期寿命<1年及沟通困难者。
临床怎么用
- 对老年非透析CKD衰弱患者,可考虑实施基于CGA的个体化多域干预以促进衰弱逆转。
- 干预以3期CKD患者为主,对更晚期CKD患者的适用性需谨慎评估。
局限性
- 研究结论可能不适用于更晚期CKD患者。
- 未观察到对非计划住院和全因死亡的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Frailty is highly prevalent among older adults with chronic kidney disease (CKD), yet evidence for targeted intervention remains limited. We evaluated whether a comprehensive geriatric assessment (CGA)-based individualized intervention could reverse frailty in this population. METHODS: In this randomized controlled trial conducted at Beijing Chao-yang Hospital, 242 frail patients with CKD (age ≥ 65, stage 3-5 nondialysis CKD, Fried score ≥ 3; excluding life expectancy < 1 year and communication difficulties) were allocated 1:1 to an intervention group receiving a 12-month individualized, CGA-based multidomain program encompassing tailored nutrition, psychological, and physical-function components or to a control group receiving routine care. The primary outcome was frailty reversion at 12 months (transition from Fried frailty score ≥ 3 to < 3), with secondary outcomes of unplanned hospitalization and all-cause mortality. RESULTS: A total of 242 participants were enrolled (mean age 79.98 ± 7.52 years, 55.8% male, 74% had stage 3 CKD). At 12 months, frailty reversion was significantly higher in the intervention group than in the control group (30.6% vs. 7.4%, P < 0.001). Logistic regression confirmed that the CGA-based individualized intervention was independently associated with a higher likelihood of frailty reversion (age-adjusted odds ratio [OR] 5.22, 95% confidence intervals [CI]: 2.37-11.49). No significant differences were observed between groups in unplanned hospitalization or all-cause mortality. CONCLUSION: CGA-based individualized intervention effectively and safely reversed frailty in older nondialysis patients with CKD, predominantly with stage 3 disease. However, no significant impact on unplanned hospitalization or mortality was observed. These findings may not be generalizable to patients with more advanced CKD.
引用
- Chang J, Liang Y, Jiang Y, et al. Randomized Controlled Trial of Individualized Intervention for Frailty Reversal in Older Patients With Nondialysis CKD. Kidney Int Rep. 2026. PMID: 42305257. doi:10.1016/j.ekir.2026.106595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。